Showing all 3 results
-
Alluvi BPC-157 & TB-500 Blend 40mg | Dual-Peptide Laboratory Research Formulation
£100.00Alluvi BPC-157 & TB-500 (40mg total) combines two well-documented investigational peptides into a single, high-purity research formulation. Engineered for comparative cell biology and regenerative signaling research, this co-formulation allows researchers to evaluate cellular migration, angiogenic signaling, and tissue matrix repair pathways in controlled in-vitro models. Supplied strictly for laboratory R&D and analytical investigation.
-
Alluvi Glow GHK-Cu (10mg / 10mg / 50mg) | Research-Grade Triple-Agonist Peptide
£100.00Alluvi Retatrutide offers high-purity, research-grade peptide formulations available in stated 10mg, 10mg multi-unit, and high-yield 50mg analytical presentations. Engineered for laboratory and in-vitro study, Retatrutide is an investigational triple-receptor agonist targeting GLP-1, GIP, and glucagon pathways to support reproducible metabolic and receptor-binding research. Strictly for laboratory R&D use.
-
Alluvi Retatrutide 40mg — Research-Grade Triple Agonist Pre-Filled Pen
£100.00High-purity Alluvi Retatrutide (20mg) formulated for controlled laboratory investigation. As an investigational GLP-1, GIP, and glucagon receptor agonist, each batch is independently verified for consistency and supplied exclusively for qualified non-clinical R&D applications.
